Opal Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Opal Wealth Advisors's VRTX Position: Q1 2026 in Review
Opal Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 5.2% in Q1 2026, buying an estimated $13.5K and bringing the position to 590 shares worth $263K. The position accounts for 0.06% of the portfolio, ranked #167.
Opal Wealth Advisors first reported a position in VRTX in Q1 2024 and has held it in 6 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Opal Wealth Advisors held 590 shares of Vertex Pharmaceuticals worth $263K as of Q1 2026.
- Opal Wealth Advisors bought 29 Vertex Pharmaceuticals shares in Q1 2026, an estimated $13.5K.
- Vertex Pharmaceuticals made up 0.06% of Opal Wealth Advisors's portfolio in Q1 2026, its #167 holding.
- Opal Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 6 quarters since.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Opal Wealth Advisors's 13F filing for Q1 2026, filed 14 Apr 2026.